CHIMERA BIOENGINEERING
They aspire to control the immune system. By the time a patient is sitting in front of an oncologist, cancer has evaded their immune system. Chimeric antigen receptor T-cells (CARs) are reprogrammed immune cells, hot-wired to circumvent immune-evasion. Clinical trials for CARs against liquid tumor cancers, like acute lymphoblastic leukemia and lymphoma, have shown transformative results for patients unresponsive to standard therapy. However, limited efficacy against solid tumor cancers, life... -threatening toxicities, and limited persistence are impediments to these therapies making a wider impact on cancer patients. Chimera Bioengineering solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program the "software" of the immune system. They design CAR behavior that promises to minimize toxicity, maximize efficacy and extend persistence so that CARs can lead to cures.w
CHIMERA BIOENGINEERING
Social Links:
Industry:
Bioinformatics Biotechnology Genetics Health Care
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.chimera.bio
Total Employee:
11+
Status:
Active
Contact:
(310)497-0736
Total Funding:
30.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business GoDaddy DNS Google GStatic Google Static Content
Similar Organizations
ACT Genomics
ACT Genomics is a cancer molecular information service company teamed up with experts with multiple years’ experience in oncology
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Fabric Genomics (formerly Omicia)
Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
Asian Fund For Cancer Research
Asian Fund For Cancer Research investment in Grant - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Convertible Note - Chimera Bioengineering
Life Science Angels
Life Science Angels investment in Venture Round - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Series A - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Seed Round - Chimera Bioengineering
Kairos Ventures
Kairos Ventures investment in Seed Round - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Convertible Note - Chimera Bioengineering
The Angels' Forum
The Angels' Forum investment in Convertible Note - Chimera Bioengineering
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-28 | Chimera Appoints New CEO, Wins AFCR BRACE Award, and Accelerates towards the Clinic with TME-Modifying CAR-T Therapies for Solid Tumors |
Official Site Inspections
http://www.chimera.bio
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Chimera Bioengineering"
Chimera Bioengineering - Crunchbase Company Profile …
Chimera Bioengineering solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program the "software" of the immune …See details»
People | Chimera Bio
At Chimera, we believe that a candidate is more than a resume. Human beings have stories, and sometimes those stories aren’t highlighted by the school you went to or the experience you …See details»
Chimera Bioengineering - LinkedIn
Chimera Bioengineering Biotechnology Research South San Francisco, California 1,150 followers We aspire to bring life, agency and dignity to cancer patients and their communities.See details»
Chimera Bioengineering - A Kairos Ventures Portfolio …
Chimera Bioengineering is a biotherapeutics company building RNA based gene regulatory systems for chimeric antigen receptor CAR-T cell therapeutics with …See details»
Chimera Bioengineering | San Francisco, CA, US Startup
Chimera Bioengineering Reprogramming life to fight cancer. Stage Product In Development Industry Biotechnology Location San Francisco, CA, US Currency USD Founded March 2015 …See details»
Chimera Bioengineering — Hypatia Group Inc.
Chimera Bioengineering is a biotherapeutics company building RNA based gene regulatory systems for chimeric antigen receptor CAR-T cell therapeutics with greater efficacy against …See details»
Chimera Bioengineering Company Profile - Craft
Chimera Bioengineering has 5 employees at their 1 location. See insights on Chimera Bioengineering including office locations, competitors, revenue, financials, executives, …See details»
Chimera Bioengineering Overview | SignalHire Company Profile
Organization Website: chimera.bio : Chimera Bioengineering industries Biotech: Headquarters Location: 329 Oyster Point Blvd, South San Francisco, California, 94080 US 329 Oyster Point …See details»
Chimera Bioengineering - PitchBook
Chimera Bioengineering was founded in 2015. Where is Chimera Bioengineering headquartered? Chimera Bioengineering is headquartered in South San Francisco, CA. What is the size of Chimera Bioengineering? Chimera …See details»
Chimera Bioengineering - Overview, News & Similar companies
Feb 24, 2021 Chimera Bioengineering contact info: Phone number: (310) 430-9893 Website: chimera.bio What does Chimera Bioengineering do? At Chimera Bioengineering, our mission …See details»
Science - Chimera Bio
Chimera has created novel CAR-T cells with genetic engineering technology to address the challenges in the field of cell therapy. Learn more about our scientific pipeline targeting solid …See details»
Vlad Hogenhuis - Chimera Bio
Vlad Hogenhuis, M.D. is the Chief Executive Officer of Chimera Bioengineering. He holds an MBA from The Wharton School. ... He previously served as a member of the Board of Directors of …See details»
ChimeraBio - Crunchbase Investor Profile & Investments
ChimeraBio is a biological investment firm specialized in seed and early stage venture investments.See details»
Chimera Bioengineering Company Information - Funding, …
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
New Ourobionics CHIMERA launched: An all-in-one multi …
Mar 14, 2025 “This CHIMERA platform is a game-changer for scientist, industrial, and medical professionals working at the forefront of tissue engineering, regenerative medicine, synthetic …See details»
Chimera – Optimizing Drug Combinations of Existing Compounds
Patent filed September 24th 2019, UNIGE licenced by Chimera Bio B.V. in 2022. A total of 10 compounds were included in the study. VIEW ALL ARTICLES. More information or a …See details»
DNA organization offers clues for advancing stem cell therapy
Apr 16, 2025 DNA organization offers clues for advancing stem cell therapy. UC Riverside-led study could help advance treatments for injuries, aging, and diseases. Author: Iqbal Pittalwala. …See details»
Ben Wang | Chimera Bioengineering
Dr. Ben Wang is co-founder and COO of Chimera Bioengineering. Prior to his role at Chimera, he was co-founder at Svaya Nanotechnologies, which developed and commercialized …See details»
DNA organization offers clues for advancing stem cell therapy
6 days ago Stem cells are at the heart of development, aging, cancer biology, and regeneration. Our study shows how histone chaperones maintain stem cell identity, making them pivotal for …See details»
Amplitude entropy captures chimera resembling behavior in the …
1 day ago Epilepsy is a neurological disease characterized by epileptic seizures, which commonly manifest with pronounced frequency and amplitude changes in the EEG signal. In …See details»